Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
49°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AbbVie Inc
Recent news which mentions AbbVie Inc
< Previous
1
2
Next >
Jim Cramer suggests why it's hard to own traditional 'safety' stocks here
May 14, 2025
Tags
General Mills Inc
Stock markets
Abbvie Inc
From
CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
May 07, 2025
Tags
AstraZeneca PLC
Business
Biotechnology
From
CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
May 05, 2025
Tags
Companies
Politics
Breaking News: Politics
From
CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
May 02, 2025
Tags
Merck & Co Inc
Amgen Inc
Mergers
From
CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
April 30, 2025
Tags
Social issues
Merck & Co Inc
Healthy Returns
From
CNBC.com News
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
April 17, 2025
Tags
Northrop Grumman Corp
Business News
Lockheed Martin Corp
From
CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
April 09, 2025
Tags
Pharmaceuticals
Biotech and Pharmaceuticals
Breaking News: Business
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Investment strategy
Breaking News: Investing
Moderna Inc
From
CNBC.com News
Ad spending on women's sports more than doubled last year
March 11, 2025
Tags
Business News
Nike Inc
Restaurant Brands International Inc
From
CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
March 04, 2025
Tags
Amazon/com Inc
Novo Nordisk A/S
Structure Therapeutics Inc
From
CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
February 04, 2025
Tags
stocks
Business News
Stock Picks
From
CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
Tags
Business
Biotechnology
Breaking News: Business
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
Toll Brothers Inc
Caterpillar Inc
Stock markets
From
CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
October 16, 2024
Tags
GXO Logistics Inc
U/S/ Markets
Investment Strategy
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
August 22, 2024
Tags
Arthur J/ Gallagher & Co/
Intuitive Surgical Inc
Investment strategy
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Health care industry
Novartis AG
AstraZeneca PLC
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Breaking News: Politics
Johnson & Johnson
Healthy Returns
From
CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
May 01, 2024
Tags
Health & Science
Abbvie Inc
Teva Pharmaceutical Industries Ltd
From
CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
February 20, 2024
Tags
Biotechnology
Abbvie Inc
Business
From
CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
February 14, 2024
Tags
Aerospace and defense industry
Breaking News: Business
Business News
From
CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
February 08, 2024
Tags
Mad Money
Markets
Investment strategy
From
CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
Tags
Biotech and Pharmaceuticals
Pharmaceuticals
Johnson & Johnson
From
CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
Tags
Pfizer Inc
Health care industry
Merck & Co Inc
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
Mad Money
Karuna Therapeutics Inc
Investment strategy
From
CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
December 13, 2023
Tags
Health & Science
Earnings
Business
From
CNBC.com News
5 things to know before the stock market opens Thursday
December 07, 2023
Tags
Markets
Politics
Citigroup Inc
From
CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
December 06, 2023
Tags
Health & Science
Biotechnology
Companies
From
CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
November 30, 2023
Tags
Health care industry
Seagen Inc
Pfizer Inc
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
Chevron Corp
Abbvie Inc
Western Digital Corp
From
CNBC.com News
Cramer's Lightning Round: Energy Transfer is a buy
October 13, 2023
Tags
Mad Money
Portillos Inc
Markets
From
CNBC.com News
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.